+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
3SBio Inc - logo

3sbio is a biotechnology company that creates biopharmaceutical products. The company was incorporated in 2006, and is headquartered in Shenyang, China. It is a subsidiary of Decade Sunshine Limited. Their products include TPIAO, a recombinant human thrombopoietin for thrombocytopenia; and EPIAO, an injectable recombinant human erythropoietin for anemia associated with chronic kidney disease (CKD) and chemotherapy, as well as to reduce allogeneic blood transfusion in surgery patients. 3sbio sell their products to a range of countries including: Brazil, Colombia, Costa Rica ,Dominican Republic, Egypt, El Salvador, Guatemala, Laos, Mongolia, Myanmar, Pakistan, Paraguay, Philippines, Sri Lanka, Thailand and Trinidad and Tobago.

From
Global and China Monoclonal Antibody Industry Report, 2019-2025 - Product Thumbnail Image

Global and China Monoclonal Antibody Industry Report, 2019-2025

  • Report
  • April 2019
  • 180 Pages
  • China, Global
From
From
From
Collaboration Deals in Pharmaceuticals 2019-2024 - Product Thumbnail Image

Collaboration Deals in Pharmaceuticals 2019-2024

  • Report
  • September 2024
  • 1150 Pages
  • Global
From
Licensing Deals in Pharmaceuticals 2019-2024 - Product Thumbnail Image

Licensing Deals in Pharmaceuticals 2019-2024

  • Report
  • September 2024
  • 1400 Pages
  • Global
From
Musculoskeletal Collaboration and Licensing Deals 2016-2024 - Product Thumbnail Image

Musculoskeletal Collaboration and Licensing Deals 2016-2024

  • Report
  • October 2024
  • 250 Pages
  • Global
From
From
Macular Edema - Global Clinical Trials Review, H2, 2021 - Product Thumbnail Image

Macular Edema - Global Clinical Trials Review, H2, 2021

  • Clinical Trials
  • December 2021
  • 350 Pages
  • Global
From
Autoimmune Collaboration and Licensing Deals 2016-2024 - Product Thumbnail Image

Autoimmune Collaboration and Licensing Deals 2016-2024

  • Report
  • October 2024
  • 500 Pages +
  • Global
From
From
From
Joint Venture Deals in Pharmaceuticals and Biotechnology 2016-2024 - Product Thumbnail Image

Joint Venture Deals in Pharmaceuticals and Biotechnology 2016-2024

  • Report
  • September 2024
  • 250 Days
  • Global
From
Biosimilar Interleukins Global Market Report 2024 - Product Thumbnail Image

Biosimilar Interleukins Global Market Report 2024

  • Report
  • February 2024
  • 250 Pages
  • Global
From
From
Biosimilars Global Market Report 2024 - Product Thumbnail Image

Biosimilars Global Market Report 2024

  • Report
  • February 2024
  • 250 Pages
  • Global
From
Rheumatoid Arthritis - Pipeline Review, H2 2020 - Product Thumbnail Image

Rheumatoid Arthritis - Pipeline Review, H2 2020

  • Drug Pipelines
  • July 2020
  • 1191 Pages
  • Global
From
From
Loading Indicator